IMMP Immutep gains 565 after Q1 2026 minor EPS miss investors stay optimistic on its clinical pipeline CPAY Corpay shares edge up 081 percent despite narrow EPS miss and strong Q4 2025 year over year revenue growth The competitive edge that makes ASGN Inc ASGN special Momentum Fading 20260511 ARRY Array Tech Q4 2025 revenue rises 402 YoY but slight EPS miss sends shares 096 lower